HOB Biotech Group Corp Ltd (688656) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.019x

Based on the latest financial reports, HOB Biotech Group Corp Ltd (688656) has a cash flow conversion efficiency ratio of 0.019x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.28 Million ≈ $2.24 Million USD) by net assets (CN¥820.01 Million ≈ $119.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HOB Biotech Group Corp Ltd (688656) defensive interval to measure how many days the company can operate on defensive assets alone.

HOB Biotech Group Corp Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how HOB Biotech Group Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

HOB Biotech Group Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HOB Biotech Group Corp Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
DBV Technologies S.A. PA:DBV	-0.236x
Amerant Bancorp Inc. NYSE:AMTB	0.024x
Shandong Bohui Paper Industry Co Ltd SHG:600966	0.177x
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	0.041x
MetroCity Bankshares NASDAQ:MCBS	0.063x
Plymouth Industrial REIT Inc NYSE:PLYM	0.036x
AcadeMedia AB (publ) ST:ACAD	0.200x
ScanSource Inc NASDAQ:SCSC	0.079x

Annual Cash Flow Conversion Efficiency for HOB Biotech Group Corp Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of HOB Biotech Group Corp Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see HOB Biotech Group Corp Ltd (688656) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥820.01 Million ≈ $119.99 Million	CN¥72.94 Million ≈ $10.67 Million	0.089x	-28.63%
2024-12-31	CN¥812.14 Million ≈ $118.84 Million	CN¥101.22 Million ≈ $14.81 Million	0.125x	-1.61%
2023-12-31	CN¥810.73 Million ≈ $118.64 Million	CN¥102.69 Million ≈ $15.03 Million	0.127x	+69.36%
2022-12-31	CN¥779.57 Million ≈ $114.08 Million	CN¥58.31 Million ≈ $8.53 Million	0.075x	-45.04%
2021-12-31	CN¥770.00 Million ≈ $112.68 Million	CN¥104.79 Million ≈ $15.33 Million	0.136x	-51.76%
2020-12-31	CN¥206.39 Million ≈ $30.20 Million	CN¥58.22 Million ≈ $8.52 Million	0.282x	-38.44%
2019-12-31	CN¥149.64 Million ≈ $21.90 Million	CN¥68.57 Million ≈ $10.03 Million	0.458x	+31.16%
2018-12-31	CN¥133.12 Million ≈ $19.48 Million	CN¥46.51 Million ≈ $6.81 Million	0.349x	+24.05%
2017-12-31	CN¥79.03 Million ≈ $11.56 Million	CN¥22.26 Million ≈ $3.26 Million	0.282x	+148.76%
2016-12-31	CN¥56.71 Million ≈ $8.30 Million	CN¥6.42 Million ≈ $939.60K	0.113x	--

About HOB Biotech Group Corp Ltd

SHG:688656 China Medical Devices

Market Cap

$979.53 Million

CN¥6.69 Billion CNY

Market Cap Rank

#9159 Global

#2328 in China

Share Price

CN¥105.45

Change (1 day)

+0.83%

52-Week Range

CN¥96.69 - CN¥213.11

All Time High

CN¥213.11